Omar Salem, MD
Dermatopathology · Sylvania, OHNPI 1952300550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 48 payments — averaging $99.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$621
- Novartis$473
- Johnson & Johnson$459
- E.r. Squibb & Sons, L.L.C.$404
- Sun Pharmaceutical Industries Inc.$350
- Sanofi$322
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,772100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $621 |
| Novartis | 5 | $473 |
| Johnson & Johnson(3 entities) | 5 | $459 |
| E.r. Squibb & Sons, L.L.C. | 4 | $404 |
| Sun Pharmaceutical Industries Inc. | 3 | $350 |
| Sanofi | 3 | $322 |
| Janssen Scientific Affairs, LLC | 3 | $321 |
| Boehringer Ingelheim | 3 | $293 |
| Pfizer | 2 | $200 |
| Lilly USA, LLC | 3 | $167 |
| Regeneron Healthcare Solutions, Inc. | 2 | $154 |
| Boston Scientific | 1 | $150 |
| Dermavant Sciences, Inc. | 1 | $124 |
| Galderma Laboratories, L.p. | 1 | $121 |
| Novo Nordisk | 1 | $115 |
| Amarin Pharma, Inc. | 1 | $110 |
| Almirall LLC | 1 | $89 |
| Integra Lifesciences Corporation | 1 | $88 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $79 |
| LEO Pharma Inc. | 1 | $77 |
| Lifenet Health | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,772 in reported general payments places this provider in the 75th percentile of 25 dermatopathology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 26 | $1,586 |
| Fluorouracil | 17 | $1,110 |
| Metronidazole | 36 | $1,075 |
| Ammonium Lactate | 29 | $605 |
| Imiquimod | 30 | $492 |
| Fluocinonide | 19 | $491 |
| Doxycycline Hyclate | 18 | $427 |
| Ketoconazole | 16 | $290 |
| Hydrocortisone | 12 | $142 |
| Triamcinolone Acetonide | 15 | $96 |
| Methylprednisolone | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Sylvania
- Melissa PiliangCleveland$123K
- Neera Agarwal AntalHudson$39K
- Adam HesselDublin$11K
- Katherine FeningMayfield Heights$10K
- Lindsey DohseChillicothe$7K
- Joshua WeaverAkron$3K
- Janet WieselthierLyndhurst$3K
- Stephen SomachCleveland$3K
- Kimberly HollandsworthCleveland$2K
- Kyle WagamonWarren$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.